Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine

Elvire Pons-Tostivint; Jaafar Bennouna

doi:10.3390/curroncol29100558

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine

Curr Oncol. 2022 Sep 28;29(10):7106-7108. doi: 10.3390/curroncol29100558.

Authors

Elvire Pons-Tostivint¹, Jaafar Bennouna²

Affiliations

¹ Medical Oncology, Centre Hospitalier Universitaire Nantes, Nantes University, F-44000 Nantes, France.
² Department of Medical Oncology, Hospital Foch, F-92150 Suresnes, France.

Abstract

In recent years, advances in molecular diagnostics have transformed the management of advanced non-small-cell lung cancer (NSCLC), allowing for increasingly personalized approaches [...].

Publication types

Editorial

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Lung Neoplasms* / drug therapy
Lung Neoplasms* / therapy
Molecular Targeted Therapy
Precision Medicine

Grants and funding

This research received no external funding.